Investors are closely watching the latest ASCO data released Thursday 6pm ET. Results seem likely to move the market.
As CNBC's Mike Huckman explained earlier in the week on Fast Money, the American Society of Clinical Oncology (ASCO) releases new data about cancer treatments on its website ahead of its annual meeting and the results are widely followed by both the medical community and investors.
Often times the data moves stocks.
Since Fast Money airs before the results were made public Huckman was only able to speculate but he told us findings could move a slew of players including OSI Pharmaceuticals, Cougar Biotech , Medarex, Exelixis, Genomic Health and Allos .